ES2057601T3 - Antagonistas de receptores muscarinicos. - Google Patents

Antagonistas de receptores muscarinicos.

Info

Publication number
ES2057601T3
ES2057601T3 ES90917103T ES90917103T ES2057601T3 ES 2057601 T3 ES2057601 T3 ES 2057601T3 ES 90917103 T ES90917103 T ES 90917103T ES 90917103 T ES90917103 T ES 90917103T ES 2057601 T3 ES2057601 T3 ES 2057601T3
Authority
ES
Spain
Prior art keywords
alkyl
independently
receptor antagonists
muscarinic receptor
piracinilo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90917103T
Other languages
English (en)
Inventor
Alexander Roderick Mackenzie
Peter Edward Cross
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2057601T3 publication Critical patent/ES2057601T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

ANTAGONISTAS RECEPTORES MUSCARINICOS. ANTAGONISTAS RECEPTORES MUSCARINICOS, PARTICULARMENTE UTILES EN EL TRATAMIENTO DEL SINDROME DE INTESTINO IRRITABLE, CON LA FORMULA O UNA SAL FARMACEUTICAMENTE ACEPTABLE, EN DONDE M ES 1 O 2; R1 Y R1 SON INDEPENDIENTEMENTE H, C1-C4 ALQUILO O JUNTOS REPRESENTAN -(CH2)P H O C1-C4 ALQUILO; EN DONDE Z ES UN ENLACE DIRECTO, -CH2-, -CH2O NDE R5 Y R6 SON CADA UNO INDEPENDIENTEMENTE H, C1-C4 ALQUILO, C1-C4 ALCOXI, -(CH2)NOH, HALO, TRIFLUOROMETILO, CIANO, -(CH2)NNR7R8, -CO(C1-C4 ALQUILO), -OCO(C1-C4 ALQUILO), -CH(OH)(C1-C4 ALQUILO), -C(OH)(C1-C4 ALQUILO)2, -SO2NH2, -(CH2)NCONR7R8 O -(CH2)NCOO(C1-C4 ALQUILO); R7 Y R8 SON CADA UNO INDEPENDIENTEMENTE H O C1-C4 ALQUILO; N ES 0, 1 O 2; X Y X1 SON CADA UNO INDEPENDIENTEMENTE O O CH2; Q ES 1, 2 O 3; Y "HET" ES PIRIDILO, PIRACINILO O TIENILO.
ES90917103T 1989-12-12 1990-11-28 Antagonistas de receptores muscarinicos. Expired - Lifetime ES2057601T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898928043A GB8928043D0 (en) 1989-12-12 1989-12-12 Muscarinic receptor antagonists

Publications (1)

Publication Number Publication Date
ES2057601T3 true ES2057601T3 (es) 1994-10-16

Family

ID=10667814

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90917103T Expired - Lifetime ES2057601T3 (es) 1989-12-12 1990-11-28 Antagonistas de receptores muscarinicos.

Country Status (13)

Country Link
US (1) US5300516A (es)
EP (1) EP0505379B1 (es)
JP (1) JPH0686428B2 (es)
AT (1) ATE108776T1 (es)
CA (1) CA2067759C (es)
DE (1) DE69010917T2 (es)
DK (1) DK0505379T3 (es)
ES (1) ES2057601T3 (es)
FI (1) FI96024C (es)
GB (1) GB8928043D0 (es)
IE (1) IE63421B1 (es)
PT (1) PT96142B (es)
WO (1) WO1991009014A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602516D0 (en) * 1996-02-08 1996-04-10 Chiroscience Ltd Racemisation
DE19843793C2 (de) * 1998-09-24 2000-08-03 Gruenenthal Gmbh Substituierte Benzamide
DE10002509A1 (de) * 2000-01-21 2001-07-26 Gruenenthal Gmbh Substituierte Glutarimide
AU2016371762A1 (en) * 2015-12-14 2018-06-21 Cyclerion Therapeutics, Inc. Use of sGC stimulators for the treatment of gastrointestinal sphincter dysfunction

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
US2848455A (en) * 1955-07-18 1958-08-19 Ciba Pharm Prod Inc Alpha-(p-amino-phenyl)-alpha-lower alkyl glutarimides
US3125578A (en) * 1962-05-17 1964-03-17 xxviii
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
GB8716338D0 (en) * 1987-07-10 1987-08-19 Nat Res Dev Anti-anxiogenic compositions

Also Published As

Publication number Publication date
US5300516A (en) 1994-04-05
IE904461A1 (en) 1991-06-19
DK0505379T3 (da) 1994-09-12
ATE108776T1 (de) 1994-08-15
JPH04505926A (ja) 1992-10-15
CA2067759A1 (en) 1991-06-13
PT96142A (pt) 1991-09-30
EP0505379B1 (en) 1994-07-20
FI96024B (fi) 1996-01-15
IE63421B1 (en) 1995-04-19
EP0505379A1 (en) 1992-09-30
PT96142B (pt) 1997-05-28
FI96024C (fi) 1996-04-25
CA2067759C (en) 1996-09-10
DE69010917D1 (de) 1994-08-25
JPH0686428B2 (ja) 1994-11-02
WO1991009014A1 (en) 1991-06-27
FI922342A7 (fi) 1992-05-22
DE69010917T2 (de) 1994-11-03
GB8928043D0 (en) 1990-02-14
FI922342A0 (fi) 1992-05-22

Similar Documents

Publication Publication Date Title
ES2082013T3 (es) Antagonistas de receptores muscarinicos.
ES2060020T3 (es) Derivados de pirrolidina.
ES2064771T3 (es) Antagonistas de los receptores muscarinicos.
ES2043624T3 (es) Compuestos de piperidina, su preparacion y su uso.
HUT64745A (en) Process for producing (+)-alpha-(2,3-dimethoxi-phenyl)-ethyl-4-piperidine-methanole
NO930599D0 (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
NO930600D0 (no) Heterocykliske forbindelser og deres fremstilling og anvendelse
CO5090837A1 (es) Derivados de 1,3,4-oxadiazolona
PL352551A1 (en) C16 unsaturated analoques of prostaglandines selective in respect to fp
ES2057601T3 (es) Antagonistas de receptores muscarinicos.
ES2102353T3 (es) Antagonistas del receptor muscarinico.
IT8819886A0 (it) Procedimento e dispositivo per sostituire gli attrezzi di foggiatura nell'unita' di chiusura di macchine per iniettofusione.
ATE113949T1 (de) Alpha-adrenergische rezeptorantagonisten.
ES2051990T3 (es) Antagonistas de receptores muscarinicos.
FI922346A0 (fi) Muscarinreceptorantagonister.
ZA894096B (en) Alpha-adrenergic receptor antagonists
EP0491873A4 (en) Therapeutic compositions; methods for treatment of hiv infections
IT9021785A0 (it) Cilindro di regolazione dell'infessione
ZW6989A1 (en) &-adrenergic receptor antagonists
IT8801236A0 (it) Macchina e metodo di ammagliamento per catena del tipo "madre-figlia"
IT1213684B (it) Contropalo o simile per l'infissione di pali di fondazione senza successiva scapitozzatura
CS39388A1 (en) Generator for telephone sets' multifrequency pulsing
IT8721860A0 (it) Apparecchio per l'iniezione e ladispersione di sorbenti desolforanti nelle camere di combustione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 505379

Country of ref document: ES